Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.3551 | 0.6747 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.1911 | 0.3063 | 1 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.4999 | 1 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.1911 | 0.3063 | 0.3063 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.3551 | 0.6747 | 0.5 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.4999 | 1 | 1 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.1911 | 0.3063 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.1911 | 0.3063 | 1 |
Brugia malayi | hypothetical protein | 0.135 | 0.1804 | 0.1804 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.3551 | 0.6747 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0561 | 0.003 | 0.003 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.1911 | 0.3063 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.1911 | 0.3063 | 0.3063 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.4999 | 1 | 1 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.3551 | 0.6747 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.1911 | 0.3063 | 0.3063 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.3551 | 0.6747 | 0.5 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.178 | 0.277 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.135 | 0.1804 | 0.1804 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.4999 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.3551 | 0.6747 | 0.5 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.1911 | 0.3063 | 1 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.4999 | 1 | 1 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.1911 | 0.3063 | 0.3063 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.3551 | 0.6747 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.3551 | 0.6747 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | 0 | Antibacterial activity against methicillin-resistant Staphylococcus aureus 562 infected orally dosed Swiss albino mouse after 7 days | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against methicillin-resistant Staphylococcus aureus 562 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against methicillin-resistant Staphylococcus aureus 33 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against vancomycin-resistant Enterococcus faecium 6A after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against Streptococcus pyogenes ATCC 19615 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
MIC (functional) | > 16 ug ml-1 | Antibacterial activity against Streptococcus pneumoniae ATCC 6303 after 24 hrs by agar dilution method | ChEMBL. | 17980588 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.